Imunon
IMNN
Imunon (IMNN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- −$0.54
- EPS estimate
- −$0.89
- EPS surprise
- +39.15%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Aug 11, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 11, 2026 | −$0.89 | −$0.54 | +39.15% | $0.00 | SEC |
| Q1 2026 | May 12, 2026 | −$1.22 | −$0.84 | +30.86% | $0.00 | SEC |
| Q4 2025 | Mar 31, 2026 | −$1.41 | −$1.24 | +11.97% | $0.00 | SEC |
| Q3 2025 | Nov 13, 2025 | −$1.20 | −$1.16 | +3.22% | $0.00 | SEC |
| Q2 2025 | Aug 5, 2025 | −$4.14 | −$1.87 | +54.85% | $0.00 | SEC |
| Q1 2025 | May 12, 2025 | −$4.57 | −$3.65 | +20.00% | $0.00 | SEC |
| Q4 2024 | Feb 27, 2025 | −$4.67 | −$3.26 | +30.17% | $0.00 | SEC |
| Q3 2024 | Nov 7, 2024 | −$5.06 | −$4.43 | +12.37% | $0.00 | SEC |
| Q2 2024 | Aug 14, 2024 | −$7.04 | −$6.65 | +5.56% | $0.00 | SEC |
| Q1 2024 | May 13, 2024 | −$7.39 | −$6.78 | +8.24% | $0.00 | SEC |
| Q4 2023 | Mar 28, 2024 | −$7.65 | −$6.52 | +14.77% | $0.00 | SEC |
| Q3 2023 | Nov 14, 2023 | −$8.61 | −$4.83 | +43.94% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$9.20 | −$7.96 | +13.48% | $0.00 | SEC |
| Q1 2023 | May 11, 2023 | −$8.54 | −$8.87 | −3.82% | $0.00 | SEC |
| Q4 2022 | Mar 30, 2023 | −$11.09 | −$19.17 | −72.94% | $125,000.00 | SEC |
| Q3 2022 | Nov 14, 2022 | −$10.57 | −$11.35 | −7.41% | $125,000.00 | — |
| Q2 2022 | Aug 15, 2022 | −$14.64 | −$11.35 | +22.49% | $125,000.00 | — |
| Q1 2022 | May 16, 2022 | −$13.17 | −$23.74 | −80.20% | $125,000.00 | — |
| Q4 2021 | Mar 31, 2022 | −$11.74 | −$8.87 | +24.44% | $110,000.00 | — |
| Q3 2021 | Nov 15, 2021 | −$16.63 | −$11.74 | +29.41% | $125,000.00 | — |
Quarterly revenue
Frequently asked questions
When did Imunon (IMNN) last report earnings?
Imunon last reported on Aug 11, 2026, covering fiscal Q2 2026.
Did IMNN beat earnings estimates?
Yes. Imunon reported EPS of −$0.54 for Q2 2026 against a −$0.89 estimate — a 39.15% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.